my account  log out
 

CAS 83150-76-9 Octreotide Acetate

Create: 11/23/2016
Expired Date:11/23/2017
Category: Raw materials [Health&Medical&Pharmaceutical]
Message:Product Name: Octreotide Acetate Alias: Sodium Deoxyribose Guarylic Acid,Acetic Octreotide,Octreotide,Sandostatin CAS: 83150-76-9 MF: C49H66N10O10S2 MW: 1019.28 Purity: 98.0%min Grade: Pharmaceutical Grade Appearance: White Powder Single Impurity (HPLC) : 1.0%max Amino Acid Composition : ±10% of theoretical Peptide Content (N%) : ≥80.0% Water Content(Karl Fischer) : ≤7.0% Acetate Content(HPIC) : ≤12.0% Specific Rotation (20/D) : -45.0~-50.0°(c=0.5 95%HAc) MS (ESI) : Consistent Mass Balance : 95.0~105.0% Storage: Closed, below 2 ~ 8℃ preservation Manufacturer: Hezhong Usage: octreotide acetate, as an injectable depot formulation for the treatment of growth hormone producing tumors (acromegaly and gigantism). Description Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer.
City:Jinan Shandong[CN] 
Location:
 
Dec 21 2016CAS 593-51-1 Methylamine HCL435
Dec 21 2016CAS 83915-83-7 Lisinopril446
Dec 21 2016CAS 141922-90-9 Azasetron HCL433
Dec 21 2016CAS 15307-79-6 Diclofenac Sodium433
Dec 21 2016CAS 104987-11-3 Tacrolimus444
Dec 21 2016CAS 68-96-2 17alpha-Hydroxyprogesterone456
Dec 21 2016CAS 5534-09-8 Beclometasone Dipropionate441
Dec 18 2016SR9011437
Dec 18 2016CAS 118237-47-0 RAD-140455
Dec 18 2016CAS 1202044-20-9 MK-2866432

return back

Copyright © toextrade Inc. All rights reserved. Contact us